相关实验视频
Updated: Jul 9, 2025

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.0K
基于常规超声波的优化策略,用于诊断与代谢功能障碍相关的脂肪性肝病
Xiongcai Feng1, Junzhao Ye1, Hong Deng2
1Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510000, China.
Diagnostics (Basel, Switzerland)
|December 9, 2023
概括
传统的超声波经常误诊代谢功能障碍相关的脂肪性肝病 (MASLD). 结合超声波与代谢因子和实验室测试的新策略显著提高了MASLD查准确度.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医疗成像医学成像
- 诊断的准确性 诊断的准确性
背景情况:
- B模式超声波在诊断与代谢功能障碍相关的脂肪性肝病 (MASLD) 中存在局限性.
- 了解影响MASLD查超声波精度的因素至关重要.
- 现有的诊断方法需要优化,以有效检测MASLD.
研究的目的:
- 调查影响MASLD查中的超声波性能因素.
- 优化基于超声波的MASLD查策略.
- 为了提高MASLD的诊断准确度.
主要方法:
- 未来的试点队列研究,包括1489名中国受试者.
- 包括一个验证队列 (426名患者) 与肝脏组织学评估.
- 单独使用超声波与综合策略的比较,包括代谢因素 (代谢功能障碍组件的数量) 和实验室测试 (ALT,尿酸).
主要成果:
- 超声波误诊了62.2%的非MASLD患者,错过了6.1%的MASLD患者.
- 较少的代谢功能障碍成分和较低的ALT水平与错过诊断有关.
- 综合策略显著改善了接收器操作特征曲线 (AUROC) 下的面积,从研究队列中的0.66到0.84和验证队列中的0.83到0.92.
结论:
- 代谢功能障碍组件的数量和ALT水平是超声波对MASLD的诊断局限性的关键因素.
- 一种新的查策略,将超声波与代谢参数和特定实验室测试相结合,大大提高了MASLD检测的有效性.
- 这种改进的策略为MASLD的查提供了更准确的方法.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
111
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
111
Ultrasonography
4.5K
Ultrasonography is an imaging technique that uses high-frequency sound waves to visualize the body's internal structures. It is a non-invasive and safe procedure that does not involve the use of ionizing radiation, making it widely used in various medical fields. Ultrasonography is used to study heart function, blood flow in the neck or extremities, certain conditions such as gallbladder disease, and fetal growth and development.
During an ultrasonography procedure, a handheld device called...
During an ultrasonography procedure, a handheld device called...
4.5K

